The Valley Desk

NCT04509674 · Interventional trial

EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

Overall registry status Completed

Phase 3

Conditions Myocardial Infarction

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov